Lipodystrophy Clinical Trial
Official title:
The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
NCT number | NCT03407313 |
Other study ID # | CLP-0002 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 8, 2018 |
Est. completion date | April 23, 2019 |
Verified date | January 2021 |
Source | Recros Medica, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. RFR is used to remove loose skin and fat.
Status | Completed |
Enrollment | 68 |
Est. completion date | April 23, 2019 |
Est. primary completion date | December 28, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years and older |
Eligibility | Inclusion Criteria: - Healthy male or female, at least 30 years old - Moderate submental (neck) fat - Mild to moderate submental (neck) skin laxity (loose skin) - Willing and able to provide informed consent - Willing and able to comply with all protocol requirements - Willing to limit direct sun exposure and use sunscreen for duration of the study - Agree to maintain weight for duration of the study - Willing to have photographs taken that could identify the participant Exclusion Criteria: - Previous intervention to treat submental fat or skin laxity - Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure - Sensitivity to local anesthesia - Severe acne, cystic acne or acne scars on neck - Trauma of chin or neck area - Skin infection or rash on neck - Psoriasis, eczema, rosacea, or vitiligo - History of scarring - History or current symptoms of dysphagia - Chronic or persistent coughing - Body mass index (BMI) > 30 - Clinically significant bleeding disorder - Anemia, kidney disease, or liver disease |
Country | Name | City | State |
---|---|---|---|
United States | Aesthetx | Campbell | California |
United States | DeNova Research | Chicago | Illinois |
United States | Sundaram Dermatology, Cosmetic & Laser Surgery Center | Fairfax | Virginia |
United States | Miami Dermatology & Laser Institute | Miami | Florida |
United States | Steve Yoelin, MD Medical Associates, Inc. | Newport Beach | California |
United States | Roseville Facial Plastic Surgery | Roseville | California |
Lead Sponsor | Collaborator |
---|---|
Recros Medica, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With a Reduction of Submental Skin Area = 20 mm^2 | This endpoint is the difference in the measurement of submental skin area (mm^2) between Baseline and 90 days. A reduction of = 20 mm^2 denotes improvement. | Baseline and 90 days post treatment | |
Secondary | Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline | Subjects rated their satisfaction of the appearance of their neck and jawline on a Subject Satisfaction Questionnaire. Results reflect subjects who were satisfied ("somewhat satisfied", "satisfied", or "very satisfied"). | 90 days after treatment | |
Secondary | Number of Participants With Post-treatment Images Correctly Identified | Correct identification of post-treatment images by three blinded independent reviewers in more than 50% of subjects | Pre-treatment and 90 days after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05419037 -
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
|
||
Recruiting |
NCT03059121 -
The Cleveland Cardiometabolic Cohort
|
||
Completed |
NCT00656175 -
Raltegravir Therapy for Women With HIV and Fat Accumulation
|
Phase 2 | |
Completed |
NCT00006185 -
Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome
|
Phase 1 | |
Completed |
NCT00202241 -
The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS
|
N/A | |
Recruiting |
NCT02262832 -
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
|
Phase 3 | |
Completed |
NCT01679197 -
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
|
Phase 2 | |
Completed |
NCT02647853 -
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT00715546 -
Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
|
Phase 1 | |
Completed |
NCT00069004 -
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
|
N/A | |
Completed |
NCT00025883 -
Leptin to Treat Lipodystrophy
|
Phase 2 | |
Completed |
NCT00001142 -
Metabolism and Body Shape of Healthy Children and Children With Chronic Infections
|
N/A | |
Active, not recruiting |
NCT02262806 -
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
|
Phase 2 | |
Completed |
NCT02258685 -
Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
|
||
Completed |
NCT00192621 -
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
|
Phase 4 | |
Completed |
NCT00006190 -
A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy
|
Phase 4 | |
Recruiting |
NCT05930106 -
Carotid Doppler Peak Velocity Variation in Liposuction Fluid Management
|
N/A | |
Completed |
NCT00004329 -
Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy
|
N/A | |
Recruiting |
NCT04656054 -
Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
|
||
Completed |
NCT00082628 -
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
|
Phase 3 |